Tag Archives: PAH

Limited Distribution Drugs, Specialty Pharmacy

Specialty Pharmacy News Roundup: March 2024

Posted on by John Santilli

The latest specialty pharmacy news and insights. Stay up to date on industry and company trends with Specialty Pharmacy Database and client-specific research.

Continue reading →
Specialty Drug

JNJ’s UPTRAVI (selexipag) Receives FDA Approval for Intravenous Use in Adults

Posted on by John Santilli
02
Aug

The FDA approved UPTRAVI® (selexipag) injection for intravenous (IV) use for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adult patients with WHO functional class (FC) II–III, who are temporarily unable to take oral therapy

Continue reading →